Eisai Co., Ltd.

We give first thought to patients and their families, and to increasing the benefits health care provides

May 25, 2012: SANNOVA RECEIVES APPROVAL FOR ADDITIONAL INDICATION, ADDITIONAL DOSAGE AND ADMINSITRATION OF KAYTWO® SYRUP 0.2% FOR PREVENTION OF VITAMIN K DEFICIENCY HEMORRHAGE IN NEONATES AND INFANTS
May 22, 2012: EISAI LAUNCHES NEW MOBILE WEBSITE TO SUPPORT REFLUX ESOPHAGITIS PATIENTS IN TAKING THEIR MEDICATION
May 18, 2012: EISAI TO PRESENT NEW RESEARCH ON ONCOLOGY PRODUCT PORTFOLIO AND PIPELINE AT 48^th ASCO ANNUAL MEETING

May 16, 2012: IR “Annual Financial Results Explanation for the Fiscal Year Ended March 31, 2012 [Material, Webcast] ”
May 15, 2012: IR “Annual Financial Results for the Fiscal Year Ended March 31, 2012 ”
May 7, 2012: Access to Medicines “Eisai's advocacy activities ”
March 30, 2012: Commitment & Passion for hhc “Interacting with Cancer Patients at Kawashima Industrial Park-Experiencing Patient Emotions Firsthand ”

May 23, 2012: Notice of Convocation of the 100th Ordinary General Meeting of Shareholders
May 21, 2012: Correction of the English Reference Data
May 16, 2012: Haruo Naito Assumes Role of President of the Federation of Pharmaceutical Manufacturers' Associations of Japan
May 15, 2012: Corporate Governance Report Updated

: Understanding Eisai
: Annual Report
: Environmental and
Social Report